Chatbot to Maximize Hereditary Cancer Genetic Risk Assessment

Evaluation of a Chatbot to Maximize Hereditary Cancer Genetic Risk Assessment in an Underserved Gynecology Population

In this study, the investigators aim to compare a mobile health platform, known as a 'chatbot,' that leverages artificial intelligence and natural language processing to scale communication, to 'usual care' that patients would receive. This comparison will enable the investigators to determine if the chatbot system can improve rates of recommendation for genetic testing among patients at elevated risk of harboring a familial cancer syndrome in an all-Medicaid gynecology clinic. Furthermore, the investigators aim to evaluate facilitators of inequity in regard to patient access to and utilization of genetic testing services.

Inclusion Criteria:

• 8 years of age or older.
• Scheduled for a New Patient appointment in the gynecology clinic. Speaks and reads in English.
• Access to a telephone with texting capacity.
• Has not had prior genetic testing for hereditary cancer syndromes.

Exclusion Criteria:

• Under 18 years of age
• Has had previous genetic testing for hereditary cancer syndromes
• Does not read/speak in English
• Does not have access to a phone with texting capabilities